US-based medical technology company Dfine has introduced its new energy-responsive, ultra-high viscosity StabiliT ERX bone cement for use with the company’s vertebral augmentation system.
According to the company, the StabiliT vertebral augmentation system uses radiofrequency-targeted vertebral augmentation (RF-TVA), to repair vertebral compression fractures and treat pain in osteoporosis and cancer patients.
StabiliT ERX bone cement, which has five times greater viscosity than other Polymethylmethacrylate (PMMA) bone cements and about two times the viscosity of Dfine’s StabiliT ER2 cement, is used to treat complex osteoporotic and oncologic fractures with large voids.
In addition to higher viscosity, StabiliT ERX bone cement provides extended working time, giving physicians procedural flexibility, and offers greater radiopacity during cement delivery for improved visibility under fluoroscopy.
Radiology Imaging Associates interventional radiologist Dr Nick Yee said patients with complex fractures such as non-healed vertebra plana are difficult to treat as these fractures have a limited amount of bone to work and stabilise the vertebra.
“With its significantly higher viscosity, StabiliT ERX affords a more targeted and controlled delivery – potentially reducing the likelihood of extravasation while still allowing for easy delivery into the vertebral body,” Yee said.
Dfine chief executive officer Kevin Mosher said the combination of RF energy, targeted navigation and controlled delivery of ultra-high viscosity cement enables physicians to provide fracture reduction with minimal damage to native bone and greater precision in cement delivery.
“Now with the introduction of StabiliT ERX as the latest advancement in our family of energy-responsive cements, physicians have greater choice in tailoring their treatments to each particular patient situation when using the StabiliT System,” Mosher said.